EN-VISION AMERICA, INC.

EN-VISION AMERICA, INC. specializes in the design, manufacturing, and deployment of specialized audio-enabled prescription dispensing systems for federal healthcare operations. Their core technical expertise lies in developing audible prescription reading devices and pharmacy printers that deliver voice-guided medication instructions to visually impaired or low-vision veterans. These systems integrate secure print-on-demand functionality with tactile and auditory feedback mechanisms, ensuring compliance with ADA and Section 508 accessibility standards. The company’s differentiated capability centers on ruggedized, FDA-regulated medical device manufacturing tailored for high-volume, mission-critical pharmacy environments, with a focus on reliability, auditability, and seamless integration into VA clinical workflows. The contractor maintains a consistent, long-term relationship with the Department of Veterans Affairs, delivering mission-critical pharmaceutical accessibility solutions across multiple VA medical centers. Their work supports VA’s broader initiative to enhance medication adherence and patient safety through assistive technology, with recurring contracts for hardware refreshes, system upgrades, and accessory supply chains. This pattern indicates deep institutional trust and alignment with VA’s accessibility and telehealth modernization goals. Operating under NAICS 334290, EN-VISION AMERICA, INC. focuses on the niche segment of communications equipment manufacturing for medical applications, specifically devices that bridge digital prescription data with physical, voice-assisted output. This positions them as a specialized vendor in the assistive medical hardware market, serving federal healthcare systems requiring compliant, durable, and user-centered pharmaceutical interfaces. As a 2L entity based in Palmetto, Florida, the company operates as a small business without federal certifications. Their geographic footprint is centralized in Florida, with a market presence defined by targeted, high-impact engagements within the VA ecosystem rather than broad federal diversification.